Biote Reports Fourth Quarter and Full Year 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/26/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Fox Factory sells Marucci Sports for $225M, cuts debt
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
biote Corp. (BTMD) PT Lowered to $6.80 at Jefferies
March 14, 2025 12:21 PM EDTJefferies analyst Kaumil Gajrawala lowered the price target on biote Corp. (NASDAQ: BTMD) to $6.80 (from $9.24) while maintaining a Buy rating.
The analyst comments "Q4 wasn't great. Sales and EBITDA missed putting the full-year at the low end of the range. 2025... More
